252 related articles for article (PubMed ID: 12560463)
1. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
Davids V; Kidson SH; Hanekom GS
Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
[TBL] [Abstract][Full Text] [Related]
4. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
5. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
[TBL] [Abstract][Full Text] [Related]
6. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
[TBL] [Abstract][Full Text] [Related]
7. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
9. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
[TBL] [Abstract][Full Text] [Related]
10. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1998 May; 16(5):1760-9. PubMed ID: 9586889
[TBL] [Abstract][Full Text] [Related]
12. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
[TBL] [Abstract][Full Text] [Related]
14. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
[TBL] [Abstract][Full Text] [Related]
15. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
[TBL] [Abstract][Full Text] [Related]
16. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS
Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770
[TBL] [Abstract][Full Text] [Related]
17. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
[TBL] [Abstract][Full Text] [Related]
18. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Bilchik AJ; Saha S; Wiese D; Stonecypher JA; Wood TF; Sostrin S; Turner RR; Wang HJ; Morton DL; Hoon DS
J Clin Oncol; 2001 Feb; 19(4):1128-36. PubMed ID: 11181678
[TBL] [Abstract][Full Text] [Related]
19. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
Rimoldi D; Lemoine R; Kurt AM; Salvi S; Berset M; Matter M; Roche B; Cerottini JP; Guggisberg D; Krischer J; Braun R; Willi JP; Antonescu C; Slosman D; Lejeune FJ; Liénard D;
Melanoma Res; 2003 Oct; 13(5):511-20. PubMed ID: 14512793
[TBL] [Abstract][Full Text] [Related]
20. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
